Irish drug that could cure Parkinson’s Disease sold for $446 million
Dr. Jeremy Skillington, Vice President of Business Development for Inflazome, travelled to Philadelphia to participate in our Life Sciences Forum this January. In one of the largest deals in Irish biotech history, Inflazome, based out of Trinity, has been sold to Roche.
The Dublin-based drug sells opening treatment of Alzheimer’s, Parkinson’s, and cardiovascular disease to the market.
An Irish company that develops treatments for inflammatory diseases, a collaboration between Trinity College Dublin and the University of Queensland, has been sold for an up-front payment of $446m (€380m) from Roche, plus additional payments based on the achievement of certain milestones.
Forbes names ICON in list of Best Employers in America for Women
ICON recognised as top employer for women in anonymous survey of 75,000 employees
DUBLIN–(BUSINESS WIRE) — ICON plc, (NASDAQ: ICLR) a leading global provider of drug development and commercialisation services to the pharmaceutical, biotechnology and medical device industries today announced that it has been recognised in the 2020 Forbes List of America’s Best Employers for Women for the second consecutive year.
Almac ranked number 5 on Ulster Business top 100 companies list
County Armagh headquartered Almac Group has climbed three positions to number five in this year’s Ulster Business “Most valuable businesses” table.
The global contract development and manufacturing organisation, that provides services across the drug development lifecycle to the pharmaceutical and biotech sectors, also moved from tenth to eighth in the supplementary list of “most profitable companies in Northern Ireland”.